Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
840 hedge funds and large institutions have $64.6B invested in Allergan plc in 2014 Q4 according to their latest regulatory filings, with 151 funds opening new positions, 317 increasing their positions, 286 reducing their positions, and 57 closing their positions.
165% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 57
69% more call options, than puts
Call options by funds: $3.02B | Put options by funds: $1.79B
15% more capital invested
Capital invested by funds: $55.9B → $64.6B (+$8.66B)
12% more funds holding
Funds holding: 753 → 840 (+87)
11% more repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 286
9% more funds holding in top 10
Funds holding in top 10: 113 → 123 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.66B |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$853M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$509M |
| 4 |
Jennison Associates
New York
|
+$464M |
| 5 |
MCM
Marsico Capital Management
Denver,
Colorado
|
+$317M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP
Jana Partners
New York
|
-$607M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$598M |
| 3 |
SC
Sculptor Capital
New York
|
-$373M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$261M |
| 5 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$250M |
AGN Hedge Fund Activity: Q4 2014 in Review
840 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2014, worth a combined $64.6B — up 15% from $55.9B a quarter earlier.
Buyers outnumbered sellers: 151 funds opened new AGN positions and 57 closed out — a net gain of 94 holders — while 317 added to existing stakes and 286 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.66B. The largest seller was Jana Partners, exiting entirely with an estimated $607M sold.
- 840 institutional investors held Allergan plc (AGN) as of Q4 2014, up from 753 in Q3 2014.
- Funds reported $64.6B of Allergan plc stock for Q4 2014, up 15% quarter-over-quarter.
- 151 funds opened new Allergan plc positions in Q4 2014 and 57 closed out, a net change of +94 holders.
- The largest Allergan plc buyer in Q4 2014 was T. Rowe Price Associates, an estimated $1.66B added.
- The largest Allergan plc seller in Q4 2014 was Jana Partners, an estimated $607M sold.
Based on aggregated 13F filings for Q4 2014.